Sentences with phrase «big pharma firms»

He wasn't surprised that startup CEOs spoke up while the major players did not: «There are a lot more ways for the Trump administration to hurt Big Pharma firms with products on the market than there are ways for the Trump administration to hurt biotech firms.»

Doing so, says Gartner biotech analyst Stephen Davies, will require forging still closer ties to big pharma firms — the lumbering giants whose inefficiency spurred Wojcicki to action in the first place.

Not exact matches

Specialty pharmacies — pharmacies that act as a separate distribution and billing mechanism for big drug firms — aren't unheard of in the world of big pharma, but Valeant's relationship with Philidor was strangely close.

Add one more name to the new slew of pharma companies trying to counteract the public backlash to big drug price increases: France's Sanofi, a $ 126 billion firm known for its flagship diabetes and vaccines units.

As big firms in sectors like pharma increasingly fret over the overhead of internal skunkworks, says Tam, they are drawn to the «unbelievable» potential cost - savings of the open approach.

IN TODAY»S biotech industry, start - up companies sprout from every university biology department, looking to hook up with big pharma or agrochemical firms to take their patented, DNA - based ingenuity lucratively to market.

«Big pharma has been fairly resilient, with pharmaceutical firms continuing to hire for drug development.

As «big pharma is actively seeking out investigations to do reformulations of existing small molecules into nanoparticles,» notes McNeil, there has been an uptick in career opportunities in both big and small firms in this sector, including startups.

That's less than biotechnology (at $ 365 billion) and pharmaceuticals (at $ 1094 billion), but it's a big industry — according to a report by the consulting firm Frost & Sullivan, it's projected to grow over the next 3 to 5 years at an annual rate of 9 %, a growth rate comparable to big pharma.

Peter Pitts wrote a stinging attack on Nissen in The Washington Times; he is a senior vice president at the PR firm Manning Selvage & Lee, which represents Big Pharma, including Glaxo.

«His thesis, which is no secret, is that biotech firms should be purchased by Big Pharma, which is always in need of new products.

Lyn Baranowski is a corporate development executive with experience spanning biotech, big pharma, and venture capital firms.